Convincing evidence that GLP-1R stimulating drugs are associated with anti-inflammatory, neurotrophic, and neuroprotective properties in preclinical models of NDD has led to trials of these drugs in the NDD clinic
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials
In addition, the findings still need to be clinically validated, and the specific mechanisms of differentially abundant bacteria or metabolites and lipid metabolism were not explored in depth and need further investigation
Detailed examination of the receptor oligomerisation state using N&B also demonstrated a greater population of higher order oligomers under vehicle conditions for the V229A versus WT GLP-1R
The cell arrangement was slightly disordered in groups C and D, but the pathological changes were more obvious than those in groups A1, 2 and 3
